Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Scripps Research Institute

Pharma deals during April 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

AstraZeneca signs $200m deal with Bind for cancer drug

Follows deals with Amgen and Pfizer for Bind involving its Accurin nanotechnology

- PMLiVE

Pfizer enters $210m+ nanomedicines deal with Bind

Will use Accurin technology to develop highly selective medicines

Pharma deals during March 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

Pfizer partners with hospital to research medicines for children

Children’s Hospital of Philadelphia joins CTI translational research network

- PMLiVE

Merck to develop biosimilars with Samsung-Biogen joint venture

Agreement with Samsung Bioepis covers several candidates

Pharma deals during January 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

Merck & Co extends autoimmune collaboration with Lycera

New deal could be worth more than $300m to the US biopharma company

EU flag

Five pharma companies begin antibiotic research programme

Sanofi, GSK and AstraZeneca among the collaborators on European projects

- PMLiVE

Endo to collaborate with India-based CRO GVK Biosciences

Will develop small molecule against undisclosed target in pain

- PMLiVE

Global academic research alliance to speed drug development

Includes centres from UK, US, Canada, Germany and Belgium

- PMLiVE

IQWiG, MRC and Cochrane back trial transparency campaign

AllTrials.net launches calling for all trial data to be reported

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links